Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Decibel Therapeutics to Participate in Upcoming Investor Conferences
-
Cardiol Therapeutics to Participate in Cantor Fitzgerald's Virtual Rare Orphan Disease Summit
-
Zynerba Pharmaceuticals to Participate in the Cantor Rare Orphan Disease Summit
-
Zynerba Pharmaceuticals to Participate in the Cantor Rare Orphan Disease Summit
-
MannKind Corporation to Participate in the Cantor Virtual Rare Orphan Disease Summit
-
MannKind Corporation to Participate in the Cantor Virtual Rare Orphan Disease Summit
-
AVINO CLOSES ACQUISITION OF LA PRECIOSA FROM COEUR MINING
-
Applied Genetic Technologies (AGTC) Announces Proposed Stock Offering, Size not Disclosed
-
Applied Genetic Technologies (AGTC) to Offer Common Stock
-
MicroVision's Leaders to Participate in Webcast Fireside Chat with Cantor Fitzgerald Analyst on March 22, 2022
-
AGTC Announces Proposed Public Offering of Common Stock
-
AGTC Announces Proposed Public Offering of Common Stock
-
Graphite Bio Reports Recent Business Progress and Fourth Quarter and Fiscal Year 2021 Financial Results
-
HTG Molecular Diagnostics (HTGM) Announces 3.24M Unit Private Placement at $2.31/unit
-
HTG Molecular Diagnostics Announces $7.5 Million Private Placement
-
High Tide Inc. (HITI:CN) (HITI) PT Lowered to Cdn$7 at Cantor Fitzgerald
-
NRx Pharmaceuticals (NRXP) Appoints Ira Strassberg as CFO
-
NRx Pharmaceuticals, Inc. Appoints Ira Strassberg as Chief Financial Officer and Treasurer
-
Form 424B3 Cantor Fitzgerald Income
-
Tempo Automation Secures Up To $100M in Committed Equity Financing
-
Cantor Fitzgerald Reiterates VYNE Therapeutics (VYNE) Overwight, $10 PT, Sees Company's Bromodomain and Extra-Terminal Domain Inhibitors Programs are Underappreciated
-
TerrAscend Corp. (TRSSF) PT Raised to $7.90 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates eFFECTOR Therapeutics (EFTR) at Overweight, $50 PT, "Company's Pipeline Remains Underappreciated", Expect Advancements to Move Stock Higher
-
Orchid Island Capital Announces March 2022 Monthly Dividend, and February 28, 2022 Rmbs Portfolio Characteristics
-
Form 8-K Cantor Fitzgerald Income For: Mar 11
-
SILVERSTEIN PROPERTIES, CANTOR FITZGERALD AND UNIVERSITY PLACE ASSOCIATES CELEBRATE TOPPING OUT OF LIFE SCIENCE BUILDING IN UNIVERSITY CITY, PHILADELPHIA
-
ANI Pharmaceuticals (ANIP) PT Lowered to $30 at Cantor Fitzgerald
-
Greystone Boosts CMBS Platform with New Hires
-
Tims China Confirms Financing Commitment
-
Cantor Fitzgerald Reiterates Novan (NOVN) at Overweight, Sees EPI Acquisition as "Smart and Significant Move"
-
HCM Acquisition Corp Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on March 14, 2022
-
HCM Acquisition Corp Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on March 14, 2022
-
Cantor Fitzgerald Reiterates Overweight Rating on AxoGen (AXGN)
-
Kalvista Pharmaceuticals Inc (KALV) PT Lowered to $33 at Cantor Fitzgerald
-
Cantor Fitzgerald and Silverstein Properties Close Third Qualified Opportunity Zone Fund, Approximately $600 Million of Total Capital Raised
-
Cantor Fitzgerald Reiterates TherapeuticsMD (TXMD) at Overweight, "TXMD's Opportunity to Become Leading Women's Healthcare Company Remains Underappreciated"
-
Troika Media (TRKA) Enters Firm Commitment for a $75M Senior Secured Credit Facility with Institutional Investor to Fund the Acquisition of Converge Direct LLC
-
Troika Media Group Signs a Firm Commitment for a $75 Million Senior Secured Credit Facility with a Multibillion-Dollar Institutional Investor to Fund the Acquisition of Converge Direct LLC
-
Troika Media Group Signs a Firm Commitment for a $75 Million Senior Secured Credit Facility with a Multibillion-Dollar Institutional Investor to Fund the Acquisition of Converge Direct LLC
-
Mustang Bio to Participate in Three March 2022 Investor Conferences
-
Mustang Bio to Participate in Three March 2022 Investor Conferences
-
springbig Announces 2021 Financial Highlights and Nominees for Post-Business Combination Board of Directors
-
Heron Therapeutics (HRTX) and Omeros (OMER) Top Cantor Fitzgerald's Most Shorted List; Amgen (AMGN) and PDS (PDSB) Seeing Biggest Increases
-
Brooklyn ImmunoTherapeutics Announces Closing of $12 Million Private Placement
-
Acadia Pharmaceuticals (ACAD) PT Raised to $37 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Lipocine (LPCN) at Overweight, Company's Pipeline Assets and Peak Sales Opportunities are Underappreciated
-
Fortress Biotech to Participate in Three March 2022 Investor Conferences
-
Fortress Biotech to Participate in Three March 2022 Investor Conferences
-
AGTC to Participate in Upcoming Investor Conferences
-
AGTC to Participate in Upcoming Investor Conferences

